Zhu Tao - CanSino Biologics Inc | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 55 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Erratum to "Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model" [Vaccine 42(6) (2024) 1292-1299]

Yuanyuan Ji,Xiuwen Sui, Wei Miao,Chang Wang, Qing Wang, Zhuojun Duan, Bochao Wei, Dan Wu,Menghan Wei,Juan Shao,Xiuyu Zheng,Tao Zhu

Vaccineno. 14 (2024): 3374-3374

Cited0Views0WOSBibtex

IFN- armed gE elicits superior immunogenicity compared to unmodified antigens and flagellin armed gE in mice

Jiangang Zhang, Shaodan Peng, Fang Xu, Ying Qiao, Xiaoke Ye, Yu Guan, Xiaolong Zhao, Yueran Wang, Zhongqi Shao,Tao Zhu,Weixue Si

VACCINE: X (2024): 100432-100432

Cited0Views0WOSBibtex

Safety, Immunogenicity, and Efficacy of Recombinant COVID-19 Inhalation Vaccine (Adenovirus Type 5 Vector) as Second Booster Dose Against Emerging Variants of Concern (VOC) of SARS-CoV-2 to Prevent Breakthrough Infections: An Observer-Blinded, Randomised, Phase 3, Non-Inferiority Trial

Chun Keat Chew,Ruijie Wang, Sunita Bavanandan, Norliza Zainudin, Xiaoyuan Zhao, Sumeyya Ahmed, Damenthi Nair,Li-Hua Hou,Rosnawati Yahya, Shereen Suyin Ch'ng, Lai Hui Pang, Azrini Abdul Aziz,

crossref（2024）

Cited0Views0Bibtex

Erratum to “Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model” [Vaccine 42(6) (2024) 1292–1299]

Yuanyuan Ji,Xiuwen Sui, Wei Miao,Chang Wang, Qing Wang, Zhuojun Duan, Bochao Wei, Dan Wu,Menghan Wei,Juan Shao,Xiuyu Zheng,Tao Zhu

Vaccine (2024)

Cited0Views0Bibtex

Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model

Yuanyuan Ji,Xiuwen Sui, Wei Miao, Chang Wang, Qing Wang, Zhuojun Duan, Bochao Wei, Dan Wu,Menghan Wei,Juan Shao,Xiuyu Zheng,Tao Zhu

VACCINEno. 6 (2024): 1292-1299

Cited0Views0WOSBibtex

Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteria

Juanjuan Wang,Haoran An,Ming Ding,Yanhong Liu, Shaomeng Wang,Qian Jin, Qi Wu,Haodi Dong,Qile Guo,Xianbin Tian,Jiankai Liu, Jingfei Zhang,

SCIENCE TRANSLATIONAL MEDICINEno. 727 (2023): eade0054-eade0054

Cited3Views0WOSSCIENCEBibtex

Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials

Xin Xia,Zhong-Ming Tan,Peng Wan,Hao Zheng,Rong Tang,Xiao-Qin Chen,Xi-Ling Guo,Tao Zhu,Jia-Lu Feng,Jin Zhong,Xiao-Long Li,Zhen-Yu Zhang,

JOURNAL OF INFECTIOUS DISEASESno. 6 (2023): 715-722

Cited0Views0WOSBibtex

Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults

Zhili Jin,Jingxuan Wu,Ying Wang,Tao Huang,Kexin Zhao,Jian Liu,Haomeng Wang,Tao Zhu,Jinbo Gou,Haitao Huang,Xiaofang Wu,Hang Yin,

The Journal of infection（2023）

Cited0Views0WOSBibtex

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

Jing-Xin Li,Li-Hua Hou,Jin-Bo Gou,Zun-Dong Yin,Shi-Po Wu,Fu-Zhen Wang,Zhe Zhang,Zhi-Hang Peng,Tao Zhu,Hong-Bing Shen,Wei Chen,Feng-Cai Zhu

The Lancet. Infectious diseasesno. 10 (2023): 1143-1152

Cited18Views0WOSBibtex

Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial

Jun-Dong Wu,Jing-Xin Li,Jian Liu,Hao-Meng Wang, Guang-Hui Zhou,Jin Li, Dou Wu, Xiang Chen, Yan Feng, Xiao-Yuan Qi,Xue Wang,Jin-Bo Gou,

The Lancet. Infectious diseasesno. 9 (2023): 1020-1030

Cited3Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn